Finally, the recently published atlas of metastatic tumors, collected from 10,336 patients (www.cbioportal.org/study?id=msk_impact_2017#) has reported the presence of CDKN1B mutations in 84 cases (somatic mutation rate = 0.7%). Here, CDKN1B is linked to metastatic neoplasm.